Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pirfenidone for Restrictive Chronic Lung Allograft Dysfunction

NCT03359863 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT03359863
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03359863 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pirfenidone for Restrictive Chronic Lung Allograft Dysfunction
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Completed
Start date
March 7, 2018
Completion date
October 28, 2021
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung transplant rejection, restrictive chronic lung allograft dysfunction